Skip to content
healthcare.dev

ROFLUMILAST

NDC 69292-631, ROFLUMILAST, tablet, from Amici Pharma Inc..

Product NDC
69292-631
Status
Listed
Labeler
Amici Pharma Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208236
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69292-631 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ROFLUMILAST500 ug/1

Pharmacologic classes

Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]

Package NDCNDC-11Package
69292-631-306929206313030 TABLET in 1 BOTTLE (69292-631-30)
69292-631-906929206319090 TABLET in 1 BOTTLE (69292-631-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/cb3781ff-5350-4f9a-b247-0b04eb0f2b92

Use it

Look up 69292-631 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69292-631 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69292-631. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.